Immunotherapy, Tumor Microenvironment and Survival Signaling
| Immunotherapy, Tumor Microenvironment and Survival Signaling |
| Autore | Golubovskaya Vita |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (376 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
angiogenesis
antigen loss Autophagy BCMA breast cancer cancer cancer immunotherapy cancer metabolism cancer nanomedicine cancer stem cells cancer vaccines CAR macrophage CAR T cell CAR-T CAR-T cells cardiotoxicity CD11 CD18 CD19 CD37 cell therapy cell-cell contact check point inhibitors checkpoint chemotherapy chimeric antigen receptor chimeric antigen receptors clonogenicity colorectal cancer combination therapy crosstalk DCLK1 dendritic cells electroporation hypoxia immune checkpoint inhibitor immune checkpoint inhibitors immune escape immunogenic cell death immunometabolism immunomodulation immunomodulators immunotherapeutic agent immunotherapies immunotherapy lentiviral transduction lentivirus leukemia cells lung metastasis lymphoma lytic peptides macrophages melanoma microenvironment miRNA mitochondria mitochondrial transfer myeloid-derived suppressor cells n/a nanoparticles oncolytic viral therapy pathogenesis pediatric solid tumors personalized medicine programmed cell death 1 ligand 1 programmed cell death protein 1 regulatory T cells resistance risk factors solid tumors targeted therapy targeted treatment triple-negative breast cancer tuft cells tumor tumor antigen tumor antigens tumor immune evasion tumor microenvironment tumor stem cells tumor stroma tunneling nanotubes tyrosine kinase inhibitors β2 integrins |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580205403321 |
Golubovskaya Vita
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Basis and Gene Therapies of Cystic Fibrosis
| Molecular Basis and Gene Therapies of Cystic Fibrosis |
| Autore | Engelhardt John |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (210 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
airway basal cell
baculovirus biomarker CFTR CFTR gene CFTR modulators CFTR variants CFTR-related disorders common and new pathogenic variants cyclophosphamide cystic fibrosis Cystic fibrosis disease liability drug development enterotoxin gene cluster ethnic Russian population exosomes functional assay gene therapy genotype-guided therapy genotype-phenotype correlations gut-lung axis health policies health policy human nasal epithelial cells incidence insect cells interpretation lentivirus lung lung microbiome metagenomics microvesicles miRNA molecular diagnosis MRSA newborn screening next generation sequencing Next Generation Sequencing (NGS) organoids penetrance pre-clinical in vitro models primary cells proteostasis rAAV2/HBoV1 small molecules Staphylococcus aureus superantigen survival transcriptomics transient immunosuppression trypsinogen |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557392203321 |
Engelhardt John
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||